Evertec (EVTC) Tops Q2 EPS by 1c; Increases, Extends Common Buyback Plan

Evertec (NYSE: EVTC) reported Q2 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $93.2 million versus the consensus estimate of $93.69 million.

The Board of Directors increased and extended the authorized share repurchase plan for a total of $65 million available for future use.

For earnings history and earnings-related data on Evertec (EVTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c